UFP Technologies, Inc.

UFPT Healthcare Medical Devices

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

291.67 5.52 −1.86%
Market cap
$2.3B
P/E
31.2×
Fwd P/E
23.6×
Dividend yield
—
F-score
5/9
Altman Z
6.86
Beneish M
−2.57
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
602.80 504.42 400.07 353.79 206.32 179.37 198.38 190.46 147.84 146.13
Revenue Growth
19.50% 26.08% 13.08% 71.48% 15.02% (9.58%) 4.16% 28.82% 1.17% 5.24%
Cost of Revenue
432.39 357.73 287.85 263.53 155.21 134.69 144.42 142.15 112.36 111.48
Gross Profit
170.41 146.69 112.23 90.26 51.11 44.68 53.96 48.31 35.49 34.65
SG&A Expenses
77.44 62.22 50.89 45.80 29.48 27.49 29.25 27.65 23.72 24.11
Operating Income
92.34 80.90 57.66 55.40 21.22 16.73 24.71 19.61 11.69 12.24
Non-operating Income/Expense
(9.82) (7.87) (3.76) (2.68) (0.01) (0.45) (1.06) (1.21) 0.17 0.08
Non-operating Interest Expenses
9.80 8.06 3.65 2.76 0.04 0.08 0.67 1.32 0.05 0.07
EBT
82.51 73.03 53.90 52.72 21.21 16.28 23.65 18.40 11.86 12.32
Income Tax Provision
14.20 14.04 8.98 10.93 5.32 2.91 3.90 4.09 2.65 4.35
Income after Tax
68.31 58.98 44.92 41.79 15.89 13.37 19.75 14.31 9.21 7.97
Dividends (Preferred)
— 0.00 — 0.00 — 0.00 — — — 0.00
Net Income Common
68.31 58.98 44.92 41.79 15.89 13.37 19.75 14.31 9.21 7.97
EPS (Basic)
8.87 7.69 5.89 5.52 2.11 1.79 2.66 1.95 1.27 1.11
EPS (Diluted)
8.75 7.58 5.83 5.45 2.09 1.77 2.63 1.93 1.26 1.10
Shares (Basic, Weighted)
7.71 7.67 7.62 7.56 7.52 7.48 7.42 7.35 7.25 7.19
Shares (Diluted, Weighted)
7.80 7.79 7.70 7.66 7.62 7.57 7.52 7.43 7.34 7.28
Gross Margin
28.27% 29.08% 28.05% 25.51% 24.77% 24.91% 27.20% 25.36% 24.00% 23.71%
EBIT Margin
15.32% 16.04% 14.41% 15.66% 10.28% 9.33% 12.45% 10.30% 7.91% 8.37%
EBT margin
13.69% 14.48% 13.47% 14.90% 10.28% 9.08% 11.92% 9.66% 8.02% 8.43%
Net Profit Margin
11.33% 11.69% 11.23% 11.81% 7.70% 7.45% 9.96% 7.51% 6.23% 5.45%
Free Cash Flow Margin
13.11% 10.65% 7.71% 3.02% 4.37% 11.58% 12.83% 8.38% 4.80% 1.45%
EBITDA
111.49 95.61 69.07 67.29 29.63 25.00 32.88 27.44 17.33 17.87
EBIT
92.34 80.90 57.66 55.40 21.22 16.73 24.71 19.61 11.69 12.24
Income from Continuous Operations
68.31 58.98 44.92 41.79 15.89 13.37 19.75 14.31 9.21 7.97
Consolidated Net Income/Loss
68.31 58.98 44.92 41.79 15.89 13.37 19.75 14.31 9.21 7.97
EPS (Basic, from Continuous Ops)
8.87 7.69 5.89 5.52 2.11 1.79 2.66 1.95 1.27 1.11
EPS (Basic, Consolidated)
8.87 7.69 5.89 5.52 2.11 1.79 2.66 1.95 1.27 1.11
EPS (Diluted, from Cont. Ops)
8.75 7.58 5.83 5.45 2.09 1.77 2.63 1.93 1.26 1.10
Shares (Diluted, Average)
7.80 7.79 7.70 7.66 7.62 7.57 7.52 7.43 7.34 7.28
EPS (Diluted, Consolidated)
8.75 7.58 5.83 5.45 2.09 1.77 2.63 1.93 1.26 1.10
EBITDA Margin
18.50% 18.95% 17.26% 19.02% 14.36% 13.94% 16.57% 14.41% 11.72% 12.23%
Operating Cash Flow Margin
15.25% 13.20% 10.33% 5.02% 6.93% 13.96% 15.74% 11.19% 11.82% 6.37%

Fold the line items

In millions of $ except per-share values · columns are period end dates